Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Murphy USA

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga · May 25, 2022

Zoom Video And 2 Other Stocks Insiders Are Selling

US crude oil futures traded higher, gaining around 1.5% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga · May 18, 2022

Moderna And 3 Other Stocks Insiders Are Selling

US crude oil futures traded lower, dropping around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades.

Benzinga · May 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Friday Is Your Last Chance To Buy Murphy USA Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Murphy USA (NYSE:MUSA).

Benzinga · May 11, 2022

Murphy USA's Ex-Dividend Date Is Wednesday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Murphy USA (NYSE:MUSA).

Benzinga · Feb 14, 2022

Murphy USA: Q4 Earnings Insights

Murphy USA (NYSE:MUSA) reported its Q4 earnings results on Wednesday, February 2, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 2, 2022

1 2

Organisations

Zoom Video Communications

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.